Recent Company News

• 06:57 AM ET Feb 27, 2026
  

  Transcript Intelligence: Gedeon Richter Q4 Earnings Guidance

• 06:57 AM ET Feb 27, 2026
  

  Transcript Intelligence: Gedeon Richter Q4 Earnings Q&A

• 06:57 AM ET Feb 27, 2026
  

  Transcript Intelligence: Gedeon Richter Q4 Earnings Themes

• 06:18 AM ET Feb 27, 2026
  

  EU's CHMP adopted a positive opinion recommending the granting of a marketing authorisation for Tuyory (11980.00Ft, +150.00)

• 06:56 AM ET Jan 30, 2026
  

  EU's CHMP adopted positive opinion recommending granting of marketing authorisation for Fylrevy (10740.00Ft, +130.00)

• 07:03 AM ET Jan 19, 2026
  

  Hikma Pharmaceuticals announces launch of Enoby and Xtrenbo in the US (1549.0000p, -21)

• 02:25 AM ET Sep 29, 2025
  

  Hikma Pharmaceuticals and Gedeon Richter receive FDA approval for denosumab biosimilars Enoby and Xtrenbo (1644.0000p, 0)

• 08:00 PM ET Sep 28, 2025
  

  Mayne Pharma Group notes Australian government approves NEXTSTELLIS for Pharmaceutical Benefits Scheme reimbursement (A$5.16, 0.00)

• 10:12 PM ET Aug 20, 2025
  

  RBC Capital Markets transfers ALM.SM, BIOA.B.SS, FYB.GR, others

• 01:54 AM ET May 14, 2025
  

  Mayne Pharma Group confirms the FDA Untitled Letter does not impact its ability to sell and distribute NEXTSTELLIS in the United States (A$5.93, -0.86)